A randomized, double-blind, placebo-controlled study determined that CB1 receptor antagonist selonabant was effective at blocking THC-induced effects in healthy adults, finding that selonabant significantly reduced "feeling high" 🚫🌿 and increased "alertness" ⚡ in subjects compared to a placebo.
Read Full Article
#CB1Receptor #Selonabant #THCResearch #HealthyAdults #Mindfulness
Read Full Article
#CB1Receptor #Selonabant #THCResearch #HealthyAdults #Mindfulness
PubMed
CB1 Receptor Antagonist Selonabant (ANEB-001) Blocks Acute THC Effects in Healthy Volunteers: A Phase II Randomized Controlled…
Emergency department visits due to cannabinoid-induced toxicity, including acute cannabinoid intoxication (ACI) have increased worldwide as more states have liberalized cannabis policy. ACI symptoms include anxiety, panic attacks, tachycardia, and psychosis…
👏3😁1